Mind Cure Health has announced that it is shuttering its current business strategy revolving around psychedelic medicine. The company is undergoing a company-wide workforce reduction and is halting the research and development related to its synthetic ibogaine program, as well as its “Desire Project” and iSTRYMTM app that optimizes the healing journey for both patients and clinicians before, during, and after therapy sessions.
Category Blog / Article
Published in Psychedelic Spotlight